Editor's letter
IFAs say the UK market is inundated with copycat products that possess about as much appeal as in-flight meals. A touch of creativity is urgently required if the market is finally to prosper
First, a word of warning: news that the UK market is contracting and the French market stagnating means this month's issue doesn't make for cheery summer reading.
In our cover story we look at how the UK market has shrunk for the fourth time in five years, and we also tell how Bristol & West, previously a market leader, has decided to exit the business. There seems to be suspicion on the part of independent financial advisers (IFAs) about structured products. Bravado by some UK distributors that say IFAs are advising clients to buy into structured products hides the reality that derivatives-based investments have failed to capture the imagination of IFAs or the investing public in quite the same way as they have on the Continent. In fact, IFAs say the UK market is inundated with copycat products that possess about as much appeal as in-flight meals. A touch of creativity is urgently required if the UK market is finally to prosper. Thankfully, it seems a few distributors are finally realising this, and we eagerly await news of more interesting bespoke products in the hope that other distributors don't go the same way as Bristol & West.
The French market is also suffering to a certain extent. Volumes may be up, but only just. Quite simply, more competition is required in a country that was previously famed for its structured products innovation. Investors are tired of the same old payoffs, but few companies are bothering to offer alternatives. Thankfully, Exane, for one, is bucking the trend and pushing commodity-linked products. And an amendment to French law - which lets investors convert their non-unit-linked life insurance contracts into a multi-investment policy without forfeiting tax benefits - could spur a whole host of innovative new offerings.
The lesson is that distributors and structurers must constantly explore new areas and react decisively to changing market conditions if structured products sales are to grow.
But which structurers are best placed to deliver innovation? You have the chance to tell us who you rate in our inaugural European survey. Look out for details of our monthly polls, starting in August.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net
More on Regulation
US regulators bid to save FRTB IMA, but it’s no small task
Even if industry wish-list is granted, a 2028 start date might be too soon for model adoption
Hopes rise for cross-product netting under SA-CCR
Banks want rule change in Basel III endgame to lower capital costs of clearing UST repos
Long way round: EU banks lament credit spread saga
EBA ditches some of banks’ preferred qualitative reasonings – and shortcuts – for CSRBB exclusion
Iosco chief sees no need for CCPs to hold more capital
CCPs have shown resilience in volatile times without extra skin-in-the-game, says Buenaventura
Banks urge EBA to delay risk benchmarking amid Iran conflict
Risk managers say hypothetical portfolio exercise clashes with severe market turbulence
EU officials tamp down hopes for bank capital relief
Capital cuts are not a done deal in EC’s review of competitiveness, despite US deregulation
EU regulators clash over ceding supervision to Esma
Belgian and Spanish regulators differ on drive for centralised oversight of cross-border firms
Why Trump’s latest Truth should make TradFi twitchy
Wall Street is becoming the villain in US president’s crypto movie